Thrombosis and bleeding rates
| Type of event . | Value . |
|---|---|
| Thrombotic events, n (%) | |
| No. of patients with thrombosis | 32 (13.7) |
| No. of patients with line-associated thrombosis | 17 (53.1) |
| Total thrombotic events∗ [line associated] | 36 [19] |
| Lower extremity DVT | 4 (11.1) |
| Upper extremity DVT [line associated] | 22 (61.1) [18] |
| Pulmonary embolism | 6 (16.7) |
| Cerebral venous sinus thrombosis | 2 (5.6) |
| Jugular vein thrombosis [line associated] | 2 (5.6) [1] |
| Cavernous sinus thrombosis | 0 |
| Hepatic or portal vein thrombosis | 0 |
| Days from PEG-Asp to thrombosis, median (range) | 14 (3-26) |
| Excluding line-associated thrombosis, median (range) | 16.5 (3-26) |
| Bleeding events, n (%) | |
| No. of patients with bleeding | 12 (5.2) |
| Total bleeding events | 12 |
| Bleeding severity† | |
| Major bleeding | 8 (66.7) |
| CRNMB | 4 (33.3) |
| Site of bleeding | |
| CNS hemorrhage | 3 (25.0) |
| Hematoma | 2 (16.7) |
| GI bleeding | 3 (25.0) |
| Vaginal bleeding | 3 (25.0) |
| Retinal hemorrhage | 1 (8.3) |
| Days from PEG-Asp to bleed, median (range) | 13.5 (0-24) |
| Type of event . | Value . |
|---|---|
| Thrombotic events, n (%) | |
| No. of patients with thrombosis | 32 (13.7) |
| No. of patients with line-associated thrombosis | 17 (53.1) |
| Total thrombotic events∗ [line associated] | 36 [19] |
| Lower extremity DVT | 4 (11.1) |
| Upper extremity DVT [line associated] | 22 (61.1) [18] |
| Pulmonary embolism | 6 (16.7) |
| Cerebral venous sinus thrombosis | 2 (5.6) |
| Jugular vein thrombosis [line associated] | 2 (5.6) [1] |
| Cavernous sinus thrombosis | 0 |
| Hepatic or portal vein thrombosis | 0 |
| Days from PEG-Asp to thrombosis, median (range) | 14 (3-26) |
| Excluding line-associated thrombosis, median (range) | 16.5 (3-26) |
| Bleeding events, n (%) | |
| No. of patients with bleeding | 12 (5.2) |
| Total bleeding events | 12 |
| Bleeding severity† | |
| Major bleeding | 8 (66.7) |
| CRNMB | 4 (33.3) |
| Site of bleeding | |
| CNS hemorrhage | 3 (25.0) |
| Hematoma | 2 (16.7) |
| GI bleeding | 3 (25.0) |
| Vaginal bleeding | 3 (25.0) |
| Retinal hemorrhage | 1 (8.3) |
| Days from PEG-Asp to bleed, median (range) | 13.5 (0-24) |